Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-20 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 20,00k | 101,92k | Achat | 5,10 | 658,66k | 3,13% |
| 2025-12-23 | Mr. Thomas TamberrinoChief Commercial Officer | 13,91k | 99,94k | Achat | 7,19 | 39,24k | 54,90% |
| 2025-12-23 | Dr. Arthur L. J. RosenthalIndependent Director | 13,90k | 101,47k | Achat | 7,30 | 58,84k | 30,93% |
| 2025-12-23 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 13,40k | 100,00k | Achat | 7,47 | 638,66k | 2,14% |
| 2025-11-24 | Ms. Murielle LortieIndependent Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 5,35k | 15,52% |
| 2025-11-24 | Krishan ShahInitié | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 2,20k | 48,48% |
| 2025-11-24 | Dr. Arthur L. J. RosenthalIndependent Director | 868,00 | 5,28k | Derivative Exercise and Retained Stock | 6,08 | 44,94k | 1,97% |
| 2025-11-24 | Mr. Brian R. EllacottIndependent Lead Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 70,20k | 1,03% |
| 2025-11-24 | Dr. Cynthia LavoieIndependent Director | 719,00 | 4,37k | Derivative Exercise and Retained Stock | 6,08 | 8,20k | 9,61% |
| 2025-11-19 | Dr. Mathieu BurtnykPresident | 1,49k | 9,08k | Derivative Exercise and Retained Stock | 6,11 | 43,55k | 3,53% |
| 2025-11-20 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 4,84k | 29,51k | Derivative Exercise and Retained Stock | 6,10 | 625,26k | 0,78% |
| 2025-11-20 | Mr. Rashed DewanCFO | 1,49k | 9,06k | Derivative Exercise and Retained Stock | 6,10 | 78,33k | 1,93% |
| 2024-11-18 | Krishan ShahInitié | 5,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 5,00k | - |
| 2024-09-08 | Krishan ShahInitié | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 1,48k | - |
| 2024-09-08 | Dr. Arthur L. J. RosenthalIndependent Director | 1,77k | 10,85k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 44,07k | 4,19% |
| 2024-09-08 | Mr. Brian R. EllacottIndependent Lead Director | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 69,48k | 2,18% |
| 2024-09-08 | Ms. Murielle LortieIndependent Director | 1,48k | 9,06k | Derivative Exercise and Retained Stock | 4,07 - 8,22 | 4,63k | 47,08% |
| 2025-09-09 | Dr. Cynthia LavoieIndependent Director | 756,00 | 3,29k | Derivative Exercise and Retained Stock | 4,35 | 7,48k | 11,24% |
| 2025-09-09 | Dr. Mathieu BurtnykPresident | 3,05k | 12,41k | Derivative Exercise and Retained Stock | 4,07 | 42,06k | 7,81% |
| 2025-09-08 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 16,67k | 67,90k | Derivative Exercise and Retained Stock | 4,07 | 620,42k | 2,76% |
| 2025-09-08 | Mr. Rashed DewanCFO | 16,67k | 67,90k | Derivative Exercise and Retained Stock | 4,07 | 76,84k | 27,70% |
| 2025-08-21 | Dr. Mathieu BurtnykPresident | 6,76k | 29,01k | Derivative Exercise and Retained Stock | 4,29 | 39,02k | 20,97% |
| 2025-08-15 | Dr. Arun Swarup MenawatChairman of the Board & CEO | 16,67k | 71,96k | Derivative Exercise and Retained Stock | 4,32 | 603,76k | 2,84% |
| 2025-08-15 | Mr. Rashed DewanCFO | 13,33k | 57,57k | Derivative Exercise and Retained Stock | 4,32 | 60,17k | 28,47% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.